Improve Research Reproducibility A Bio-protocol resource
Peer-reviewed
tooltip

CD8 T Cell Virus Inhibition Assay Protocol

CD8 T 细胞病毒抑制实验方法

YX Yinyan Xu *
AW Ann Marie Weideman *
MA Maria Abad-Fernandez
KM Katie R. Mollan
SK Sallay Kallon
SS Shahryar Samir
JW Joanna A. Warren
GC Genevieve Clutton
NR Nadia Roan
AA Adaora A. Adimora
NA Nancie Archin
JK JoAnn Kuruc
CG Cindy Gay
MH Michael G. Hudgens
NG Nilu Goonetilleke

 (*contributed equally to this work) 发布: 2022年03月20日第12卷第6期 DOI: 10.21769/BioProtoc.4354 浏览次数: 3899

评审: Alessandro DidonnaDhiman Sankar PalAnonymous reviewer(s)

download pdf PDF PDF
ask Q&A
引用
收藏
Cited by

参见作者原研究论文

The authors used this protocol in:

Cover of Frontiers in Immunology, featuring study using the protocol.

Jun 2021

Presubmission Inquiry

实验方案合集

专注于特定技术或应用的、详细的、经过同行评审的实验方案合集

Cancer Research
Immunology
Developmental Biology
Microbiology
Neuroscience
Cell Imaging - A Special Collection for Cell Bio 2023
查看更多 more

相关实验方案

一种基于流式细胞术利用荧光病毒样颗粒定量检测跨膜配体与其相应受体结合的方法

一种基于流式细胞术利用荧光病毒样颗粒定量检测跨膜配体与其相应受体结合的方法

Colin M. Kim [...] Ahmad Yatim

2026年07月05日 501 阅读

通过体内生物素化简便快速制备HLA-DR15 MHC II类四聚体

通过体内生物素化简便快速制备HLA-DR15 MHC II类四聚体

Xue-Yao Zhao [...] Liang Chen

2026年07月20日 202 阅读

利用重组人半乳糖凝集素体外激活Jurkat E6-1细胞的方法

利用重组人半乳糖凝集素体外激活Jurkat E6-1细胞的方法

Ruei-De Yan [...] Yi-Chang Liu

2026年08月05日 273 阅读

Abstract

The human immunodeficiency virus (HIV)-1 viral inhibition assay (VIA) measures CD8+ T cell-mediated inhibition of HIV replication in CD4+ T cells and is increasingly used for clinical testing of HIV vaccines and immunotherapies. Different VIAs that differ in length of CD8:CD4 T cell culture periods (6–13 days), purity of CD4 cultures [isolated CD4+ T cells or CD8+ depleted peripheral blood mononuclear cells (PBMCs)], HIV strains (laboratory strains, isolates, reporter viruses) and read-outs of virus inhibition (p24 ELISA, intracellular measurement of p24, luciferase reporter expression, and viral gag RNA) have been reported.

Here, we describe multiple modifications to a 7-day VIA protocol, the most impactful being the introduction of independent replicate cultures for both HIV infected-CD4 (HIV-CD4) and HIV-CD4:CD8 T cell cultures. Virus inhibition was quantified using a ratio of weighted averages of p24+ cells in replicate cultures and the corresponding 95% confidence intervals. We identify methodological and analysis changes that could be incorporated into other protocols to improve assay reproducibility. We found that in people living with HIV (PLWH) on antiretroviral therapy (ART), CD8 T cell virus inhibition was largely stable over time, supporting the use of this assay and/or analysis methods to examine therapeutic interventions.


Graphic abstract:



Keywords: CD4 (CD4) search CD8 (CD8) search HIV (HIV) search JRCSF (JRCSF) search T-cell (T-cell) search p24 (p24) search Virus inhibition (病毒抑制) search

Background

A CD8+ T cell virus inhibition assay (VIA) measures the in vitro ability of CD8+ T cells to inhibit human immunodeficiency virus (HIV)-1 replication in autologous CD4+ T cells. This assay captures the full range of CD8+ T cell anti-viral activity in response to in vitro antigen presentation of virus-derived peptides by infected CD4 T cells. VIAs are increasingly used in clinical studies but mostly as an exploratory assay, because the complex co-culture of the VIA has substantial assay variability and a limited dynamic range. Different VIAs have been reported (Yang, O. O. et al., 1997; Sáez-Cirión et al., 2009, 2010; Spentzou et al., 2010; Julg et al., 2010; Freel et al., 2011; Yang, H. et al., 2012, 2013; Naarding et al., 2014; Slichter et al., 2014; Hancock et al., 2015) that differ in length of CD8:CD4 T cell culture periods (6–13 days), purity of CD4 cultures (isolated CD4+ T cells or CD8+ depleted PBMCs), HIV strains (laboratory strains, isolates, reporter viruses), and read-outs of virus inhibition (p24 ELISA, intracellular measurement of p24, luciferase reporter expression, and viral gag RNA). Here, we describe multiple modifications to a 7-day VIA protocol, the most impactful being the introduction of independent replicate cultures for both HIV infected-CD4 (HIV-CD4) and HIV-CD4:CD8 T cell cultures. Virus inhibition was quantified using a ratio of weighted averages of p24+ cells in replicate cultures and the corresponding 95% confidence intervals (CI). We found that in people living with HIV (PLWH) on antiretroviral therapy (ART), CD8+ T cell virus inhibition was largely stable over time, supporting the use of this assay and/or analysis methods to examine therapeutic interventions.

Materials and Reagents

  1. FalconTM Round-Bottom Polystyrene Test Tubes (FalconTM, catalog number: 352054)

  2. Falcon 50 mL Conical Centrifuge Tubes (Corning, catalog number: 352070)

  3. Falcon 15 mL Conical Centrifuge Tubes (FalconTM, catalog number: 352097)

  4. Phytohaemagglutinin (PHA) (Sigma-Aldrich, catalog number: L8902-5MG)

  5. Benzonase® (Sigma-Aldrich, catalog number: NucleaseE1014)

  6. CD4+ T Cell Isolation Kit (MACS, Miltenyi-Biotec, catalog number: 130-096-533)

  7. HIV-1 JR-CSF Infectious Molecular Clone (pYK-JRCSF) NIH reagent program

  8. IL-2 (Prometheus Proleukin, Aldesleukin, catalog number: 407682M)

  9. IL-7 (PeproTech, catalog number: 200-07-10UG)

  10. Polybrene (Santa Cruz Biotechnology, catalog number: NC9840454)

  11. RPMI (Corning®, catalog number: 10-040-CV)

  12. FBS (VWR Life Science, catalog number: 97068-091)

  13. L-Glutamine (CorningTM, catalog number: 25005CI)

  14. Sodium Pyruvate (CorningTM, catalog number: 25-000-CIR)

  15. Penicillin-streptomycin (GibcoTM, catalog number: 15070063)

  16. HEPES (CorningTM, catalog number: 25-060-CI)

  17. PBS (CorningTM, catalog number: 21-030-CM)

  18. BSA (Sigma, catalog number: A8412)

  19. EDTA (CorningTM, catalog number: 46-034-CI)

  20. Lysolecithin (Sigma, catalog number: L4129-25MG)

  21. Paraformaldehyde (PFA) (Santa Cruz Biotechnology, catalog number: sc-281692)

  22. Methanol (Sigma, catalog number: 34860-1L-R)

  23. Nonidet P-40 (Biotang Inc, catalog number: BTBB914)

  24. Zombie NIR Fixable Viability Kit (Biolegend, catalog number: 423106)

  25. p24-FITCKC57-FITC (catalog number: 6604665, Beckman)

  26. CD3-BV421 (BD Biosciences, catalog number: BDB562426)

  27. CD4-AF488 (Biolegend, catalog number: 317434)

  28. CD8-BV510 (Biolegend, catalog number: 344732)

  29. Anti-mouse Ig, κ compensation beads (BDTM, catalog number: 552843)

  30. PBMCs: Isolated from PLWH receiving antiretroviral therapy (HIVART) and seronegative individuals (healthy donor (HD))

  31. R-10+ (see Recipes)

  32. R-20+ (see Recipes)

  33. Cell isolation buffer (see Recipes)

  34. 50% Methanol/PBS (see Recipes)

  35. 0.1% NP-40/PBS (see Recipes)

Equipment

  1. Centrifuges (Thermo Scientific, ST40R TX-1000, catalog number: 50144036)

  2. Muse Cell Analyzer (EMD Millipore Corporation, catalog number: 0500-3115)

  3. Incubator (Thermo Scientific, catalog number: 190408340396)

  4. MACS magnet (Miltenyi Biotech, OctoMACS Separator, catalog number: 130-042-108)

  5. Flow Cytometer (BD LSRFortessa)

  6. FINNPIPETTE F1 GLP (Thermo Scientific, catalog number: 4700850N)

Software

  1. Excel (Microsoft)

  2. Flow Jo (Flow Jo, LLC/ FlowJo_v10.8.0, https://www.flowjo.com/)

Procedure

English
中文翻译

文章信息

版权信息

© 2022 The Authors; exclusive licensee Bio-protocol LLC.

如何引用

Xu, Y., Weideman, A. M., Abad-Fernandez, M., Mollan, K. R., Kallon, S., Samir, S., Warren, J. A., Clutton, G., Roan, N., Adimora, A. A., Archin, N., Kuruc, J., Gay, C., Hudgens, M. G. and Goonetilleke, N. (2022). CD8 T Cell Virus Inhibition Assay Protocol. Bio-protocol 12(6): e4354. DOI: 10.21769/BioProtoc.4354.

ris ris Download Citation in RIS Format

分类

免疫学 > 免疫细胞功能 > 淋巴细胞

免疫学 > 免疫细胞染色 > 流式细胞术

细胞生物学 > 基于细胞的分析方法 > 病毒性感染

您对这篇实验方案有问题吗？

在此处发布您的问题，我们将邀请本文作者来回答。同时，我们会将您的问题发布到Bio-protocol Exchange，以便寻求社区成员的帮助。

post 发布问题
0 Q&A
pen 提交稿件